Ocutrx Vision Technologies Will Deliver World’s First 5G AR/XR Medical Specific Platform in 2021
July 08, 2020 06:00 ET
|
Ocutrx Vision Technologies, LLC
IRVINE, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California-based technology company developing state-of-the-art augmented reality (AR) headset devices, today...
Ocutrx Vision Technologies Will Deliver World’s First 5G AR/XR Medical Specific Platform in 2021
July 07, 2020 06:00 ET
|
Ocutrx Vision Technologies, LLC
IRVINE, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California-based technology company developing state-of-the-art augmented reality (AR) headset devices, today...
Ocutrx Vision Technologies Selects Karten Design to Refine the Final Oculenz AR Headset Design for Commercialization
June 23, 2020 08:00 ET
|
Ocutrx Vision Technologies, LLC
IRVINE, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a global technology manufacturing Augmented Reality (AR) and Extended Reality (XR) headset company is excited to...
Home OCT longitudinal home-based study with patient self-operated device has begun
June 17, 2020 07:30 ET
|
Notal Vision
Manassas, VA, June 17, 2020 (GLOBE NEWSWIRE) -- Notal Vision is proud to announce the enrollment of patients in the first longitudinal home-based study with its investigational home optical...
Ocutrx Vision Technologies Appoints Three New Directors, Adds Colorado Testing Facility, Offices in Northern and Southern California
June 16, 2020 08:00 ET
|
Ocutrx Vision Technologies, LLC
IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- In a move to support its solid growth trajectory, Ocutrx Vision Technologies, LLC, the maker of breakthrough augmented-extended reality (AR/XR)...
US FDA approves updated Novartis Beovu® label, to include additional safety information
June 11, 2020 01:15 ET
|
Novartis International AG
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients1 The...
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through the Association for Research in Vision and Ophthalmology (ARVO)
June 08, 2020 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
Ocutrx’s Oculenz Advances from AR Headset to Full Surgery Visualization Theatre
May 19, 2020 04:00 ET
|
Ocutrx Vision Technologies, LLC
KENSINGTON, London, May 19, 2020 (GLOBE NEWSWIRE) -- The maker of breakthrough augmented-extended reality (AR/XR) glasses that provide a radically new surgical viewing experience for retinal...
Graybug Vision Appoints Parisa Zamiri, Physician-Scientist with Deep Expertise in Ophthalmology, as Chief Medical Officer
May 18, 2020 07:30 ET
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc., a clinical stage biopharmaceutical company focused on developing transformative medicines to treat vision-threatening...
OVITZ Gives Optometrists A Look into their Future with a New Level of Vision Improvement
May 14, 2020 09:36 ET
|
OVITZ
ROCHESTER, N.Y., May 14, 2020 (GLOBE NEWSWIRE) -- OVITZ, a company that develops innovative vision-enhancing technologies for contact lenses, announced today that its xwave system is now in beta use...